SK bioscience and the International Vaccine Institute (IVI) announced today that the typhoid conjugate vaccine developed by SK bioscience with technology transfer from IVI has achieved the World Health Organization prequalification (PQ), which paves the way for public procurement of the vaccine by UN organizations and gives a boost to the global TCV supply.
Prostate Cancer Is Not Just an ‘Old Man’s Disease’
Gabe Canales’ experience with low-risk prostate cancer nearly matches mine — with a couple of caveats, including a 27-year difference in the ages at which
September 3, 2023